Revisión sistemática de la literatura para el manejo de dolor central en esclerosis múltiple


Autoria(s): Correa Castillo, Diana Patricia; Moreno Benavides, Carlos
Contribuinte(s)

Gutiérrez, Ángela María

Beltrán Johnny

Data(s)

2008

31/12/1969

Resumo

El dolor es un síntoma muy común en pacientes con Esclerosis Múltiple, pues del 42 al 65% de los enfermos lo presentan, y es calificado como el síntoma más severo entre el 8 y el 32%. Todos los síndromes dolorosos centrales se presentan por lesión o disfunción del sistema nervioso central, causando discapacidad severa y deterioro de la calidad de vida de los pacientes.

Background Pain is a very common symptom in patients with Multiple Sclerosis, because 42 to 65% of patients present it. As the severe symptom, pain in these patients is between 8 to 32%. All central pain syndromes are presented by injury or dysfunction of the central nervous system, causing severe disability and deterioration in the quality of life of patients.

Formato

application/pdf

Identificador

http://repository.urosario.edu.co/handle/10336/9780

Idioma(s)

spa

Publicador

Escuela de Medicina y Ciencias de la Salud

Direitos

info:eu-repo/semantics/embargoedAccess

Fonte

instname:Universidad del Rosario

reponame:Repositorio Institucional EdocUR

Neumann H, Cavalie A, Jenne DE, Wekerle H. Induction of MHC class I genes in neurons. Science 1995 Jul 28

269(5223):549-552.

Tsuchida T, Parker KC, Turner V, McFarland HF, Coligan JE, Biddison WE. Autoreactive CD8+ T cell responses to human myelin protein -derived peptides. Proc Natl Acad Sci. USA 1994

91: 10859-10863.

Zilber N, Kahana E. Pitfalls in multiple sclerosis epidemiology. En: Frontiers in Multiple Sclerosis. Clinical research and therapy. Edited O.Abramsky, H Ovadia. (Martin Dunitz 1997):22-28.

Paty DW, Oger JJF, Kastrukoff Lf et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potencials, oligoclonal banding and CT. Neurology 1988

38:180-185.

Sadovnick Ad, Ebers GC. Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci 1993

20 :17-29.

Kuroiwa Y, Igata A, Itahara K et al. Nation wide survey of multiple sclerosis in Japan. Neurology 1975

845-85.

Rosati G, Aiello I, Pirastru MI et al. Epidemiology of multiple sclerosis in northwestern Sardinia : Further evidence for higher frequency in Sardinians compared to other Italians. Neuroepidemiology 1996

15 :10-19.

Arnold DL, Matthews PM, Francis GS et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol. 1992 .31:235-241.

Demeners C, Stankoff B, Logak M, Anglade P, Allinquant B, Couraud F, Zalc B, Lubetzki C. Induction of myelination in the central nervous system by electrical activity. Proct Nat Acad Sci. 1996

93:9887-9892.

Beatty W.W., Paul R.H., Wilbanks S.L., Hames K.A., Blanco C.R. y Goodkin.D.E. Identifying multiple sclerosis patients with mild or global cognitive impairment using the screening examination for cognitive impairment (SEFCI), Neurology 1995

45: 718-723.

TEME

Palavras-Chave #Dolor #Esclerosis múltiple #Neurología #616.84
Tipo

info:eu-repo/semantics/bachelorThesis

info:eu-repo/semantics/acceptedVersion